Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?


Journal article


Navid Sobhani, Silvia P Corona, Giandomenico Roviello, Stefan Bagby, Alberto D'Angelo, Giandomenico Iezzi, Daniele Generali
Future Oncology, vol. 16(19), 2020, pp. 1327-1330

DOI: 10.2217/fon-2020-0311

Cite

Cite

APA   Click to copy
Sobhani, N., Corona, S. P., Roviello, G., Bagby, S., D'Angelo, A., Iezzi, G., & Generali, D. (2020). Immune-gene signature: a new tool for patient selection for checkpoint inhibitors? Future Oncology, 16(19), 1327–1330. https://doi.org/ 10.2217/fon-2020-0311


Chicago/Turabian   Click to copy
Sobhani, Navid, Silvia P Corona, Giandomenico Roviello, Stefan Bagby, Alberto D'Angelo, Giandomenico Iezzi, and Daniele Generali. “Immune-Gene Signature: a New Tool for Patient Selection for Checkpoint Inhibitors?” Future Oncology 16, no. 19 (2020): 1327–1330.


MLA   Click to copy
Sobhani, Navid, et al. “Immune-Gene Signature: a New Tool for Patient Selection for Checkpoint Inhibitors?” Future Oncology, vol. 16, no. 19, 2020, pp. 1327–30, doi: 10.2217/fon-2020-0311.


BibTeX   Click to copy

@article{navid2020a,
  title = {Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?},
  year = {2020},
  issue = {19},
  journal = {Future Oncology},
  pages = {1327-1330},
  volume = {16},
  doi = { 10.2217/fon-2020-0311},
  author = {Sobhani, Navid and Corona, Silvia P and Roviello, Giandomenico and Bagby, Stefan and D'Angelo, Alberto and Iezzi, Giandomenico and Generali, Daniele}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in